Inside story on SA's second Covid-19 vaccine trial: Wits vaccinology Professor Shabir Madhi

Loading player...
University of the Witwatersrand vaccinology expert Professor Shabir Madhi tells BizNews about how US drug company Novavax got to run a critical trial of its coronavirus vaccine. He shares the details of why this is a promising vaccine and picks up on the latest developments on Covid-19 vaccine trials in South Africa. Learn more about your ad choices. Visit megaphone.fm/adchoices
17 Aug 2020 4PM English South Africa Investing · Business News

Other recent episodes

Solly Moeng on the Steenhuisen bombshell and South Africa's national Shutdown

South Africa is not only dealing with a National Shutdown this week, but also with a couple of political hand grenades. In his latest chat to Chris Steyn, political commentator Solly Moeng his gives take on the alleged assassination attempt on Crime Intelligence (CI) boss General Feroz Khan just days…
30 Jun 11AM 17 min